Beating Heart Surgery Systems - Medical Devices Pipeline Assessment, 2018
June 2018
58
About the Report
About the Report
Beating Heart Surgery Systems-Medical Devices Pipeline Assessment, 2018
Summary
GlobalData's Medical Devices sector report, Beating Heart Surgery Systems-Medical Devices Pipeline Assessment, 2018 provides an overview of Beating Heart Surgery Systems currently in pipeline stage.
The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Beating Heart Surgery Systems pipeline products.
This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Beating Heart Surgery Systems under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Beating Heart Surgery Systems and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
Reasons to buy
The report enables you to-
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Beating Heart Surgery Systems under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product's current stage of development, territory and estimated launch date
Products
Products
Apaxis Medical Inc, ApiCor; Apaxis Medical Inc, EasyApex CV; Children's Hospital Boston, Heart Patch Deployment System; Children's Hospital Boston, Millimeter-Scale Device; Corazon Technologies, Inc., Beating Heart Aortic Valve Repair Demineralization System; Harpoon Medical, Inc., Harpoon TSD-5; HeartLander Surgical, Inc., HeartLander; Nido Surgical LLC, Cardioport
Companies
Apaxis Medical Inc
Children's Hospital Boston
Corazon Technologies, Inc.
Harpoon Medical, Inc.
HeartLander Surgical, Inc.
Nido Surgical LLC
Table of Contents
Table of Contents
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 4
2 Introduction 5
2.1 Beating Heart Surgery Systems Overview 5
3 Products under Development 6
3.1 Beating Heart Surgery Systems-Pipeline Products by Stage of Development 6
3.2 Beating Heart Surgery Systems-Pipeline Products by Segment 7
3.3 Beating Heart Surgery Systems-Pipeline Products by Territory 8
3.4 Beating Heart Surgery Systems-Pipeline Products by Regulatory Path 9
3.5 Beating Heart Surgery Systems-Pipeline Products by Estimated Approval Date 10
3.6 Beating Heart Surgery Systems-Ongoing Clinical Trials 11
4 Beating Heart Surgery Systems-Pipeline Products under Development by Companies 12
4.1 Beating Heart Surgery Systems Companies-Pipeline Products by Stage of Development 12
4.2 Beating Heart Surgery Systems-Pipeline Products by Stage of Development 13
5 Beating Heart Surgery Systems Companies and Product Overview 14
5.1 Apaxis Medical Inc Company Overview 14
5.1.1 Apaxis Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 14
5.2 Children's Hospital Boston Company Overview 16
5.2.1 Children's Hospital Boston Pipeline Products & Ongoing Clinical Trials Overview 16
5.3 Corazon Technologies, Inc. Company Overview 18
5.3.1 Corazon Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 18
5.4 Harpoon Medical, Inc. Company Overview 19
5.4.1 Harpoon Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 19
5.5 HeartLander Surgical, Inc. Company Overview 22
5.5.1 HeartLander Surgical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 22
5.6 Nido Surgical LLC Company Overview 23
5.6.1 Nido Surgical LLC Pipeline Products & Ongoing Clinical Trials Overview 23
6 Beating Heart Surgery Systems- Recent Developments 24
6.1 May 24, 2018: Medtronic Reports Fourth Quarter And Fiscal Year 2018 Financial Results 24
6.2 May 07, 2018: Medtronic Appoints Mike Weinstein As Senior Vice President Of Strategy 26
6.3 Apr 26, 2018: AtriCure Reports First Quarter 2018 Financial Results 27
6.4 Apr 25, 2018: Boston Scientific Reports Financial Results For First Quarter 2018 27
6.5 Apr 05, 2018: Dr. Laura Mauri to Join Medtronic as Vice President, Global Clinical Research & Analytics 29
6.6 Feb 26, 2018: AtriCure Announces Fourth Quarter and Full Year 2017 Financial Results 30
6.7 Feb 20, 2018: AtriCure Names Scott Drake Board Chairman 31
6.8 Feb 01, 2018: Boston Scientific Announces Results for Fourth Quarter and Full Year 2017 32
6.9 Jan 30, 2018: Alex Gu Named Senior Vice President and President of Medtronic's Greater China Region 34
6.10 Jan 09, 2018: Boston Scientific Announces Preliminary Unaudited Sales For The Fourth Quarter And Full Year Ended December 31, 2017 34
6.11 Jan 08, 2018: AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2017 35
6.12 Dec 19, 2017: Bob White Named Executive Vice President and President of Medtronic's Minimally Invasive Therapies Group; Chris Lee to Assume Leadership of Medtronic's Asia Pacific Region 35
6.13 Nov 21, 2017: Medtronic Reports Second Quarter Financial Results 36
6.14 Nov 08, 2017: Medtronic Announces Preliminary Second Quarter Revenue 39
6.15 Nov 02, 2017: Medtronic Releases Fiscal Year 2017 Integrated Performance Report 40
6.16 Nov 01, 2017: New Study: Innovative Heart Device is Safe and Effective 41
6.17 Nov 01, 2017: AtriCure Reports Third Quarter 2017 Financial Results 42
6.18 Oct 26, 2017: Boston Scientific Announces Results For Third Quarter 2017 43
6.19 Oct 06, 2017: Medtronic Provides Update on Impact from Hurricane Maria 44
6.20 Oct 04, 2017: Boston Scientific Appoints Desiree Ralls-Morrison General Counsel and Corporate Secretary 46
6.21 Aug 22, 2017: Medtronic Reports First Quarter Financial Results 46
6.22 Jul 27, 2017: Boston Scientific Announces Results for Second Quarter 2017 49
6.23 Jul 27, 2017: AtriCure Reports Second Quarter 2017 Financial Results 50
6.24 Jul 18, 2017: AtriCure Announces Hiring of Chief Technology Officer 51
6.25 Jun 27, 2017: Boston Scientific Outlines Strategy for Sustained Growth at 2017 Investor Day 52
7 Appendix 55
7.1 Methodology 55
7.2 About GlobalData 58
7.3 Contact Us 58
7.4 Disclaimer 58
List of Figure
1.2 List of Figures
Figure 1: Beating Heart Surgery Systems-Pipeline Products by Stage of Development 6
Figure 2: Beating Heart Surgery Systems-Pipeline Products by Segment 7
Figure 3: Beating Heart Surgery Systems-Pipeline Products by Territory 8
Figure 4: Beating Heart Surgery Systems-Pipeline Products by Regulatory Path 9
Figure 5: Beating Heart Surgery Systems-Pipeline Products by Estimated Approval Date 10
Figure 6: Beating Heart Surgery Systems-Ongoing Clinical Trials 11
List of Table
1.1 List of Tables
Table 1: Beating Heart Surgery Systems-Pipeline Products by Stage of Development 6
Table 2: Beating Heart Surgery Systems-Pipeline Products by Segment 7
Table 3: Beating Heart Surgery Systems-Pipeline Products by Territory 8
Table 4: Beating Heart Surgery Systems-Pipeline Products by Regulatory Path 9
Table 5: Beating Heart Surgery Systems-Pipeline Products by Estimated Approval Date 10
Table 6: Beating Heart Surgery Systems-Ongoing Clinical Trials 11
Table 7: Beating Heart Surgery Systems Companies-Pipeline Products by Stage of Development 12
Table 8: Beating Heart Surgery Systems-Pipeline Products by Stage of Development 13
Table 9: Apaxis Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 14
Table 10: ApiCor-Product Status 14
Table 11: ApiCor-Product Description 14
Table 12: EasyApex CV-Product Status 15
Table 13: EasyApex CV-Product Description 15
Table 14: Children's Hospital Boston Pipeline Products & Ongoing Clinical Trials Overview 16
Table 15: Heart Patch Deployment System-Product Status 16
Table 16: Heart Patch Deployment System-Product Description 16
Table 17: Millimeter-Scale Device-Product Status 17
Table 18: Millimeter-Scale Device-Product Description 17
Table 19: Corazon Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 18
Table 20: Beating Heart Aortic Valve Repair Demineralization System-Product Status 18
Table 21: Beating Heart Aortic Valve Repair Demineralization System-Product Description 18
Table 22: Harpoon Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 19
Table 23: Harpoon TSD-5-Product Status 19
Table 24: Harpoon TSD-5-Product Description 19
Table 25: Harpoon Medical, Inc.-Ongoing Clinical Trials Overview 20
Table 26: Harpoon TSD-5-First in Man-Clinical Validation of the TSD-5 21
Table 27: Harpoon TSD-5-Mitral Trans-apical Neochordal Echo-guided Repair: TRACER Trial 21
Table 28: HeartLander Surgical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 22
Table 29: HeartLander-Product Status 22
Table 30: HeartLander-Product Description 22
Table 31: Nido Surgical LLC Pipeline Products & Ongoing Clinical Trials Overview 23
Table 32: Cardioport-Product Status 23
Table 33: Cardioport-Product Description 23
Table 34: Glossary 57
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.